The balance between inhibition and substrate-type reactions of recombinant C1 inhibitor P5/P3 variants.
Eldering
E
E
Central Laboratory, The Netherlands Red Cross Blood Transfusion Service, Amsterdam.
Huijbregts
C C
CC
Nuijens
J H
JH
Hack
C E
CE
D000595:Amino Acid Sequence; D000818:Animals; D002460:Cell Line; D002522:Chlorocebus aethiops; D003174:Complement C1 Inactivator Proteins / Q000235:genetics* / Q000378:metabolism* / Q000494:pharmacology; D003173:Complement C1s / Q000378:metabolism; D015956:Factor XIIa / Q000378:metabolism; D005341:Fibrinolysin / Q000378:metabolism; D014644:Genetic Variation; D006801:Humans; D007610:Kallikreins / Q000378:metabolism; D007700:Kinetics; D008969:Molecular Sequence Data; D017354:Point Mutation; D011994:Recombinant Proteins / Q000378:metabolism / Q000494:pharmacology; D014162:Transfection
D003174:Complement C1 Inactivator Proteins; D011994:Recombinant Proteins; D007610:Kallikreins; D015956:Factor XIIa; D003173:Complement C1s; D005341:Fibrinolysin